Modulation of Remifentanil-Induced Analgesia and Postinfusion Hyperalgesia by Parecoxib or Ketorolac in Humans.
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2011
At a glance
- Drugs Ketorolac (Primary) ; Parecoxib (Primary) ; Remifentanil
- Indications Hyperalgesia
- Focus Adverse reactions; Therapeutic Use
- 02 Sep 2010 Results were presented at the 13th World Congress on Pain.
- 05 May 2009 New trial record